Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.53
+0.10
(+1.06%)
Pre-Market: 08:29
Arcutis Biotherapeutics Profit Margin (Quarterly): -92.81% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -92.81% |
| June 30, 2024 | -169.6% |
| March 31, 2024 | -71.38% |
| December 31, 2023 | -490.0% |
| September 30, 2023 | -117.5% |
| Date | Value |
|---|---|
| June 30, 2023 | -1.37K% |
| March 31, 2023 | -2.88K% |
| December 31, 2022 | -2.43K% |
| September 30, 2022 | -14.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.86K%
Minimum
Sep 2022
-71.38%
Maximum
Mar 2024
-2.50K%
Average
-490.0%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -15.75% |
| Biogen Inc | 15.76% |
| Vertex Pharmaceuticals Inc | 37.71% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -139.0% |
| Return on Assets | -49.01% |
| Return on Invested Capital | -56.93% |
| Gross Profit Margin (Quarterly) | 87.70% |
| Operating Margin (Quarterly) | -87.29% |
| Return on Net Operating Assets | -281.8% |